{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:45:57Z","timestamp":1648633557718},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/jcp.0b013e3181c06dad","type":"journal-article","created":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T08:15:39Z","timestamp":1257581739000},"page":"611-612","source":"Crossref","is-referenced-by-count":7,"title":["Vocal Tics Associated With Ziprasidone"],"prefix":"10.1097","volume":"29","author":[{"given":"Gerd","family":"Willmund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Wertenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja A.","family":"Laier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Undine E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210128","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/ajp.137.10.1267","article-title":"Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration.","volume":"137","author":"Stahl","year":"1980","journal-title":"Am J Psychiatry"},{"key":"R2-21-20210128","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.870100613","article-title":"Tardive tourettism after exposure to neuroleptic therapy.","volume":"10","author":"Bharucha","year":"1995","journal-title":"Mov Disord"},{"key":"R3-21-20210128","first-page":"419","article-title":"\"Tardive\" Tourette syndrome in relation to long-term neuroleptic treatment of multiple tics.","volume":"35","author":"Fog","year":"1982","journal-title":"Adv Neurol"},{"key":"R4-21-20210128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0006-3223(95)00218-6","article-title":"Clozapine in tardive Tourette syndrome.","volume":"38","author":"Jaffe","year":"1995","journal-title":"Biol Psychiatry"},{"key":"R5-21-20210128","first-page":"1085","article-title":"Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.","volume":"18","author":"Jeste","year":"1983","journal-title":"Biol Psychiatry"},{"key":"R6-21-20210128","first-page":"415","article-title":"Tourette-like symptoms following chronic neuroleptic therapy.","volume":"35","author":"Klawans","year":"1982","journal-title":"Adv Neurol"},{"key":"R7-21-20210128","first-page":"67","article-title":"A case of tardive Tourette-like syndrome.","volume":"46","author":"Kuniyoshi","year":"1992","journal-title":"Jpn J Psychiatry Neurol"},{"key":"R8-21-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1192\/bjp.141.2.191","article-title":"Tourette-like syndrome after long-term neuroleptic drug treatment.","volume":"141","author":"Mueller","year":"1982","journal-title":"Br J Psychiatry"},{"key":"R9-21-20210128","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0033-3182(85)72879-4","article-title":"Tardive Tourette's syndrome treated with clonidine and mesoridazine.","volume":"26","author":"Munetz","year":"1985","journal-title":"Psychosomatics"},{"key":"R10-21-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00002826-200405000-00001","article-title":"Neuroleptic-induced tardive Tourette treated with clonazepam: a case report and literature review.","volume":"27","author":"Reid","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"R11-21-20210128","first-page":"357","article-title":"Tardive dyskinesia with Tourette-like syndrome.","volume":"42","author":"Seeman","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"R12-21-20210128","first-page":"459","article-title":"Two cases of tardive Tourette syndrome.","volume":"108","author":"Yamauchi","year":"2006","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"R13-21-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JCP.0b013e318166c4d5","article-title":"Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.","volume":"28","author":"Gao","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R14-21-20210128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.CHI.0000070257.24125.91","article-title":"Ziprasidone-induced oculogyric crisis.","volume":"42","author":"Ramos","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R15-21-20210128","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1176\/jnp.15.4.458","article-title":"Ziprasidone-induced Pisa syndrome after clozapine treatment.","volume":"15","author":"Ziegenbein","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R16-21-20210128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1176\/appi.ajp.162.3.625-a","article-title":"Ziprasidone-induced acute dystonia.","volume":"162","author":"Mason","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R17-21-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.ajp.161.1.175-a","article-title":"Ziprasidone-related tardive dyskinesia.","volume":"161","author":"Keck","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R18-21-20210128","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1176\/appi.ajp.162.11.2191","article-title":"Tardive dystonia associated with ziprasidone.","volume":"162","author":"Papapetropoulos","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R19-21-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/jcp.0b013e318160864f","article-title":"Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.","volume":"28","author":"Cortese","year":"2008","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200912000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:15:00Z","timestamp":1618035300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200912000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181c06dad","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}